|
![]() Standing Together for Female Cardiac Care! Heart disease is the leading cause of death among women worldwide. Yet, women’s heart health is too often overlooked. This is why it’s time to put female cardiac care in the spotlight. At BIOTRONIK, we are united in advancing female cardiac care. Join us in our campaign to empower, educate, and lead the change for healthier hearts. ![]() ![]() BIOTRONIK will join at the European Heart Rhythm Association (EHRA) congress taking place in Vienna, Austria on March 30 – April 1, 2025. Join us for interactive sessions, lectures, hands-on experiences and networking with the BIOTRONIK professionals. Our highlights this year: Conduction System Pacing Atrial Fibrillation Management Workflow Optimization By showcasing solutions aimed at fast and effective detection, enhanced patient engagement and advanced workflow automation, we are eager to demonstrate our dedication to being a trusted partner. |
![]() BIOTRONIK Neuro’s Prospera spinal cord stimulation (SCS) system treats patients suffering from chronic pain, helping them embrace life again. The system uniquely features: RESONANCE™, the first and only multiphase stimulation paradigm Embrace One, a truly first-of-its-kind ecosystem that provides automatic, objective, remote daily monitoring Prospera SCS System is approved in the US only and is not available outside of the US. Note: Embrace One is a support platform intended to help manage a patient’s experience with spinal cord stimulation. It is not intended to be used for medical diagnosis or medical treatment. Find out more |
![]() Indicated for de novo coronary artery lesionsa Support Resorbable coronary scaffolds widen coronary artery stenoses and provide temporary vessel support. Thereby, scaffolds enable unobstructed blood flow in the coronary arteries with low rates of stent thrombosis (ST) and target lesion revascularization (TLR). Resorb By degrading after fulfilling their scaffolding function, they offer all options of future therapies. Find out more |
![]() BIOTRONIK Conduction System Pacing Solution Working alongside physicians and listening closely to their needs, we have together developed a complete Conduction System Pacing (CSP) Solution, consisting of the world's first and only approved MR Conditional CSP system1, comprehensive training, and expert technical support. BIOTRONIK’s CSP system is composed of three proven components: Selectra 3D – a broad range of optimally designed catheters delivering excellent handling2 Solia S – the most popular choice of stylet-driven leads for LBBAP3, providing enhanced stability2 Amvia – the first family of pacemakers approved for LBBAP. 1With a collaboratively developed system and practical training programs, BIOTRONIK’s CSP Solution gives you the confidence and ease to undertake left bundle branch area pacing (LBBAP) approach. Find out more |
![]() Oscar®(One Solution: Cross. Adjust. Restore) multifunctional peripheral catheter is an innovative new all-in-one device that is intended to facilitate lesion access, crossing, and restoring blood flow. It is composed of three fully user-adjustable components: Oscar support catheter with integrated Lock Grip Oscar extendable dilator Oscar length-adjustable PTA balloon The Oscar support catheter and dilator are used in tandem to enable lesion access and crossing with a compatible guidewire. Each Oscar catheter configuration contains one length adjustable PTA balloon to restore the blood flow. Find out more |
![]() BIOMONITOR IV BIOTRONIK’s latest insertable cardiac monitor, BIOMONITOR IV, comes with SmartECG, an intelligent system powered by artificial intelligence and advanced algorithms to provide actionable clinical insights.1,2 Reduces 86% of false detections across all major arrhythmias3 Streamlines ICM monitoring with intuitive templates and reports The industry’s first to discriminate between PVCs and PACs6,7 Reduce your review burden and achieve timely and accurate diagnosis to focus on what’s most important – the patient. FIND OUT MORE |
![]() All News February 27, 2025 BERLIN, Germany BIOTRONIK Driving the Future of Active Device Business February 19, 2025 BUELACH, Switzerland BIOTRONIK Begins BIOMAG-LL Pre-Market Trial to Evaluate Freesolve® Resorbable Magnesium Scaffold for Treatment of Long Lesions January 29, 2025 ORLANDO, Florida, USA New Data Show Significant Pain Relief, Reduced Opioid Use, Decreased Patient Time and Cost Burdens with the ProsperaTMSCS System January 14, 2025 BERLIN, Germany BIOTRONIK Introduces Two New Indications for the Ultrathin Strut Orsiro® Mission Drug-Eluting Stent |
![]() ![]() Blog BIOTRONIK’s Longstanding Cooperation with Die ARCHE: A Partnership for Children ![]() Heart Monitoring for Irregular Heartbeat: “I Can Now Do Sports Again Without Any Worries.” A BIOTRONIK employee shares his experience as a patient with an implantable cardiac monitor. |